
Westlake Chemical Partners LP Common Units (WLKP) Q1 2026 Earnings Call Transcript
Westlake Chemical Partners LP acquires, develops and operates ethylene production facilities and related assets in the United States. The company is headquartered in Houston, Texas.
| Revenue (TTM) | $1.23B |
| Gross Profit (TTM) | $387.53M |
| EBITDA | $494.75M |
| Operating Margin | 28.30% |
| Return on Equity | 42.40% |
| Return on Assets | 17.20% |
| Revenue/Share (TTM) | $35.03 |
| Book Value | $14.22 |
| Price-to-Book | 3.08 |
| Price-to-Sales (TTM) | 0.64 |
| EV/Revenue | 0.926 |
| EV/EBITDA | 2.58 |
| Quarterly Earnings Growth (YoY) | 186.30% |
| Quarterly Revenue Growth (YoY) | 28.60% |
| Shares Outstanding | $35.25M |
| Float | $19.44M |
| % Insiders | 44.83% |
| % Institutions | 29.13% |
Volatility is currently contracting

Westlake Chemical Partners LP Common Units (WLKP) Q1 2026 Earnings Call Transcript

HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the first quarter of 2026 of $14.2 million, or $0.40 per limited partner unit, which was above first quarter 2025 net income of $4.9 million. Cash flows from operating activities in the first quarter of 2026 were $110.2 million, an increase of $64.4 million compared to first quarter 2025 cash flows from operating activities of $45.8 million, due t.

HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 47th quarterly distribution announced by the Partnership since its initial public offering. The distribution will be payable on June 1, 2026, to unit holders of record on May 14, 2026. This release is intended to be a qualified notice under Treasury Regulation Sect.

HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") announced today that Mr. Jonathan H. Baksht will be joining the Partnership as Senior Vice President and Chief Financial Officer and as a director of Westlake Chemical Partners GP LLC, the general partner of the Partnership (the “General Partner”), effective June 15, 2026. Mr. Baksht succeeds Mr. M. Steven Bender, who, as previously disclosed, will retire by the end of the year and, effective June 15, 2026,.